by HBOT News | Sep 25, 2008 | Clinical Trials, HBOT Research, Osteoradionecrosis
There is currently not sufficient evidence that hyperbaric oxygen (HBO) benefits the surgical
removal of necrotic bone in osteoradionecrosis patients. This study aims at testing the
hypothesis that HBO does improve healing after surgical removal of necrotic bone in
irradiated previous head and neck cancer patients compared to not receiving HBO.
by HBOT News | Apr 24, 2008 | Lymphoma
Abstract: To elucidate long-term outcomes in 65 consecutive patients meeting a uniform definition of mandibular osteoradionecrosis (ORN) treated with multimodality therapy including hyperbaric oxygen (HBO). Pretreatment, post-treatment and long-term follow-up of...
by HBOT News | Apr 24, 2008 | Carcinoma
Abstract: To elucidate long-term outcomes in 65 consecutive patients meeting a uniform definition of mandibular osteoradionecrosis (ORN) treated with multimodality therapy including hyperbaric oxygen (HBO). Pretreatment, post-treatment and long-term follow-up of...
by HBOT News | Feb 27, 2008 | Necrotizing Fasciitis
Abstract: Hemodialysis dependence is an independent risk factor for hematogenous complication, including distant metastatic infection and osteomyelitis. Chronic osteomyelitis is a serious disease that fails to respond to aggressive medical and surgical treatment....
by HBOT News | Jan 5, 2008 | Cancer
Abstract: Management of irradiated patients with cancer in the head and neck region represents a challenge for multidisciplinary teams. Radiotherapy promotes cellular and vascular decrease that results in a low response rate in the healing. Consequently, surgical...
